CeriBell Stock (NASDAQ:CBLL)

Forecast Revenue Financials Chart

Previous Close

$23.33

52W Range

$18.69 - $32.75

50D Avg

$25.81

200D Avg

$26.10

Market Cap

$832.91M

Avg Vol (3M)

$215.42K

Beta

-

Div Yield

-

CBLL Company Profile

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Industry

Healthcare

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

229

IPO Date

-

Website

CBLL Performance

CBLL Financial Summary

	Dec 23	Dec 22
Revenue	$45.23M	$25.92M
Operating Income	$-30.04M	$-36.02M
Net Income	$-29.46M	$-37.16M
EBITDA	$-26.51M	$-35.06M
Basic EPS	$-1.27	$-1.59
Diluted EPS	$-1.27	$-1.59

Fiscal year ends in Dec 23 | Currency in USD